Traditional risk scores do not properly predict perioperative morbidity and mortality for retroperitoneal sarcoma resection

J Surg Oncol. 2022 Dec;126(7):1367-1368. doi: 10.1002/jso.27044. Epub 2022 Jul 30.

Affiliations

¹ Department of Surgery for Soft Tissue Sarcoma, Fondazione Policlinico Campus Bio-Medico, Rome, Italy.
² Unit of Anaesthesia, Intensive Care and Pain Management, Fondazione Policlinico Campus Bio-Medico, Rome, Italy.
³ Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁴ Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.

PMID: 35907205
DOI: 10.1002/jso.27044

No abstract available

Publication types

Letter

MeSH terms

Humans
Morbidity
Retroperitoneal Neoplasms* / surgery
Retroperitoneal Space
Retrospective Studies
Risk Factors
Sarcoma* / surgery